The tubular ACSL4 expression levels evaluated by IOD/area were significantly higher in the DKD patients than in the control subjects (0.28 ± 0.04 vs. 0.20 ± 0.04, p < 0.0001) (Figure 2B). This evidence concerns the gene ACSL4 and diabetic kidney disease.